Julie H Levison

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa
    Julie H Levison
    Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
    Clin Infect Dis 56:587-97. 2013
  2. pmc Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa
    Julie H Levison
    Division of General Medicine Massachusetts General Hospital, Boston, Massachusetts, United States of America
    PLoS ONE 7:e32144. 2012
  3. pmc Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa
    Julie H Levison
    Division of General Medicine, Massachusetts General Hospital, Boston, MA, USA
    Antivir Ther 16:853-61. 2011
  4. pmc Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial
    Sarah B Lorenzana
    Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA
    AIDS 26:1083-93. 2012

Collaborators

Detail Information

Publications4

  1. pmc The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa
    Julie H Levison
    Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
    Clin Infect Dis 56:587-97. 2013
    ..After adherence counseling, these patients may safely and effectively continue first-line ART, thereby delaying more expensive second-line ART...
  2. pmc Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa
    Julie H Levison
    Division of General Medicine Massachusetts General Hospital, Boston, Massachusetts, United States of America
    PLoS ONE 7:e32144. 2012
    ..We investigated the prevalence of wild-type virus (no major drug resistance) and drug resistance mutations at second-line antiretroviral treatment (ART) failure in a large HIV treatment program in South Africa...
  3. pmc Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa
    Julie H Levison
    Division of General Medicine, Massachusetts General Hospital, Boston, MA, USA
    Antivir Ther 16:853-61. 2011
    ..We aimed to describe predictors of lack of virological suppression in HIV-infected patients on second-line ART in a roll-out programme in South Africa...
  4. pmc Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial
    Sarah B Lorenzana
    Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA
    AIDS 26:1083-93. 2012
    ..To project the clinical and economic outcomes of a genotype assay for selection of third-line antiretroviral therapy (ART) in resource-limited settings, as per the planned international A5288 trial (MULTI-OCTAVE)...